I'm repositioning, limiting losses and looking for new opportunities. Outlook Strategies Keeping balance in a scary stock market
Mergers are driving up biotech stocks, but beware of short traders. Outlook Biotech stocks? Proceed with caution
Retail, airlines and housing stocks look promising as energy prices fall. Strategies Looking for buy signals in a volatile market
Americans have reasons to spend in confidence next year. Strategies U.S. growth looks robust heading into 2015
Biotech stocks tend to outperform in times of economic expansion. Strategies Why I added Amgen and Celgene to my portfolio
The market has been heading up too far, too fast. Strategies Risk of a major stock correction is growing
With the population aging, healthcare is a growth sector. Strategies Generic drugmaker Mylan is a smart healthcare play
We're not sure if the market is heading up or down, but will be active in our model. Strategies We’re weeding the leaders from the laggards
Healthcare reform will bring more patients and boost profits. Strategies Healthcare poised for growth under Obamacare
The month of April was kind to the Healthcare Model. Strategies Model benefits from strong healthcare gains
Essentially biotech investors assume the role of venture capitalist by funding drug companies with high failure risk. Strategies How I approach biotech investing